Biointron has established an industry-leading 2-week antibody production service, supported by a powerful high-throughput expression platform. Armed with this high-efficiency platform, our FC-MES affinity maturation system is capable of providing non-biased antibody optimization and affinity maturation in less than 2 months. Additionally, our VHH and single B-cell-based discovery projects benefit significantly and are expedited by this unique capability.
Lei Shi, PhD. is an SVP at Biointron. Prior to that, he worked for a series of biotech companies, including Virtuoso Therapeutics, Zai Lab, and Bird Rock. Lei had also worked at J&J in antibody discovery technology. He completed his Postdoc study at MGH and Harvard Medical School.
お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。